NCT05074368View on ClinicalTrials.gov

Efficacy and Safety of Heterologous and Homologous COVID-19 Vaccination

NACompletedINTERVENTIONAL
Enrollment

499

Participants

Timeline

Start Date

July 6, 2021

Primary Completion Date

April 27, 2022

Study Completion Date

May 18, 2022

Conditions
Healthy Adult Volunteers
Interventions
BIOLOGICAL

ChAdOx1-nCov-19 (Astra-Zeneca)

vaccine inoculation and mixed inoculation

BIOLOGICAL

SARS-CoV-2 messenger RNA-1273 (Moderna) vaccine

vaccine inoculation and mixed inoculation

Trial Locations (1)

10002

National Taiwan University Hospital, Taipei

All Listed Sponsors
collaborator

Taoyuan General Hospital, Ministry of Health and Welfare,Taoyuan,Taiwan

UNKNOWN

lead

National Taiwan University Hospital

OTHER